Ross Donehower

Ross Donehower

UNVERIFIED PROFILE

Are you Ross Donehower?   Register this Author

Register author
Ross Donehower

Ross Donehower

Publications by authors named "Ross Donehower"

Are you Ross Donehower?   Register this Author

59Publications

1436Reads

13Profile Views

Single-board hematology fellowship track: a 10-year institutional experience.

Blood 2018 01 11;131(4):462-464. Epub 2017 Dec 11.

Division of Hematology, Department of Medicine and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-11-816207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790129PMC
January 2018

Growing Pains: a Simulation-Based Curriculum for Improving the Transition to Hematology/Oncology Fellowship.

J Cancer Educ 2017 Sep;32(3):496-502

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-015-0974-1DOI Listing
September 2017

Familial GI Stromal Tumor With Loss of Heterozygosity and Amplification of Mutant KIT.

J Clin Oncol 2016 Jan 27;34(3):e13-6. Epub 2014 May 27.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.51.6633
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.6633DOI Listing
January 2016

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

N Engl J Med 2015 Jun 30;372(26):2509-20. Epub 2015 May 30.

From the Swim Across America Laboratory (D.T.L., J.N.U., B.R.B., L.A.D.), Sidney Kimmel Comprehensive Cancer Center (D.T.L., J.N.U., H.W., H.K., A.D.E., A.D.S., B.S.L., N.S.A., D.L., B.B., R.C.D., D.M.P., N.P., K.W.K., S.Z., B.V., L.A.D.), Ludwig Center and Howard Hughes Medical Institute (B.R.B., A.D.S., N.P., K.W.K., S.Z., B.V., L.A.D.), and the Departments of Radiology (A.Z.) and Pathology (F.B., T.H., R.H.H., L.D.W., N.C., T.C.C., J.M.T., R.A.A., J.R.E.), Johns Hopkins University School of Medicine, Baltimore; Department of Medicine, Stanford University School of Medicine, Stanford, CA (G.A.F.); Providence Cancer Center at Providence Health and Services, Portland, OR (T.S.C.); Department of Medicine, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh (J.J.L.); Bon Secours Cancer Institute, Richmond, VA (S.M.D.); Division of Medical Oncology, Ohio State University Comprehensive Cancer Center-James Cancer Center and Solove Research Institute, and Human Cancer Genetics Program, Ohio State University Comprehensive Cancer Center, Columbus (R.M.G., A.C.); and Merck, Kenilworth, NJ, and North Wales, PA (M.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1500596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481136PMC
June 2015

Interventions for preventing neuropathy caused by cisplatin and related compounds.

Cochrane Database Syst Rev 2014 Mar 31(3):CD005228. Epub 2014 Mar 31.

Department of Neurology, University of Michigan, 1C325/0032 University Hospital, 1500 E. Medical Center Drive, Box 0316, Ann Arbor, USA, MI 48109-0032.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD005228.pub4
Publisher Site
http://dx.doi.org/10.1002/14651858.CD005228.pub4DOI Listing
March 2014

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.

J Immunother 2013 Sep;36(7):382-9

The Sidney Kimmel Cancer Center, the Skip Viragh Center for Pancreatic Cancer, Research and Clinical Care, and the Sol Goldman Pancreatic Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31829fb7a2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779664PMC
September 2013

Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer.

Invest New Drugs 2013 Apr 22;31(2):345-54. Epub 2012 May 22.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting-Blaustein Cancer Research Bldg, Room 1M52, 1650 Orleans Street, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-012-9820-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674958PMC
April 2013

Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer.

Invest New Drugs 2012 Dec 1;30(6):2391-9. Epub 2012 May 1.

Department of Medical Oncology, Skip Viragh Center for Pancreatic Cancer Research and Patient Care, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting- Blaustein Cancer Research Building, Room 4M09, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-012-9818-6
Publisher Site
http://dx.doi.org/10.1007/s10637-012-9818-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557459PMC
December 2012

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.

Cancer Chemother Pharmacol 2012 Feb 29;69(2):415-24. Epub 2011 Jul 29.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB I, Room 590, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1704-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265723PMC
February 2012

Interventions for preventing neuropathy caused by cisplatin and related compounds.

Cochrane Database Syst Rev 2011 Feb 16(2):CD005228. Epub 2011 Feb 16.

Department of Neurology, University of Michigan, 1C325/0032 University Hospital, 1500 E. Medical Center Drive, Box 0316, Ann Arbor, USA, MI 48109-0032.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD005228.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715044PMC
February 2011

A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors.

Clin Cancer Res 2009 Oct 29;15(19):6241-9. Epub 2009 Sep 29.

Chemical Therapeutics Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845396PMC
October 2009

Analysis of circulating tumor DNA to confirm somatic KRAS mutations.

J Natl Cancer Inst 2009 Sep 29;101(18):1284-5. Epub 2009 Jul 29.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djp240DOI Listing
September 2009

Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater.

Radiother Oncol 2009 Aug 21;92(2):244-8. Epub 2009 Jun 21.

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, 401 N. Broadway, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2009.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700350PMC
August 2009

Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors.

Cancer Chemother Pharmacol 2008 Mar 12;61(3):423-33. Epub 2007 Apr 12.

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Cancer Research Building I, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0485-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557498PMC
March 2008

Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.

Int J Radiat Oncol Biol Phys 2007 May 2;68(1):178-82. Epub 2007 Feb 2.

Therapeutic Radiologists, Inc., Kansas City, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.11.048DOI Listing
May 2007

Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumours.

Eur J Cancer 2007 Jan 3;43(1):78-86. Epub 2006 Nov 3.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting-Blaustein Cancer Research Building, CRB 1M88, 1650 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2006.09.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852493PMC
January 2007

A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignancies.

Invest New Drugs 2006 Nov;24(6):499-508

Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-8219-0DOI Listing
November 2006

Phase II study of erlotinib in patients with advanced biliary cancer.

J Clin Oncol 2006 Jul;24(19):3069-74

Karmanos Cancer Institute, Wayne State University, 4-HWCRC, 4100 John R St, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.3579DOI Listing
July 2006

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.

J Clin Oncol 2005 Sep;23(27):6657-63

Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.14.696DOI Listing
September 2005

A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors.

Clin Cancer Res 2005 Jan;11(2 Pt 1):664-71

Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
January 2005

Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study.

Pharmacotherapy 2004 Jan;24(1):16-25

Division of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.24.1.16.34800DOI Listing
January 2004

Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile.

Clin Cancer Res 2003 Sep;9(10 Pt 1):3589-97

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21230-1000, USA.

View Article

Download full-text PDF

Source
September 2003

Is HIF-1 alpha a valid therapeutic target?

J Natl Cancer Inst 2003 Apr;95(7):498-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/95.7.498DOI Listing
April 2003

A phase I and pharmacologic study of pyrazoloacridine and cisplatin in patients with advanced cancer.

Invest New Drugs 2003 Feb;21(1):75-84

Division of Hematology and Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
February 2003

Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studies.

Clin Cancer Res 2003 Jan;9(1):151-9

Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, 3075 EA Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
January 2003

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

J Natl Cancer Inst 2002 Dec;94(24):1883-8

Division of Experimental Therapeutics, The Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21237, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/94.24.1883DOI Listing
December 2002

Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.

Clin Cancer Res 2002 Apr;8(4):963-70

The Johns Hopkins Oncology Center, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
April 2002

Evolving therapies: farnesyltransferase inhibitors.

Curr Oncol Rep 2002 Jan;4(1):29-36

The Johns Hopkins Oncology Center, 1650 Orleans Street, Bunting-Blaustein Cancer Research Building, Room 187, Baltimore, MD 21231-2410, USA.

View Article

Download full-text PDF

Source
January 2002